Back to Newsroom
Back to Newsroom

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: LM, NTGN, IOTS

Tuesday, 03 March 2020 06:10 PM

Brodsky & Smith, LLC

BALA CYNWYD, PA / ACCESSWIRE / March 3, 2020 / Brodsky & Smith, LLC reminds investors of investigations it is conducting regarding the following companies for possible breaches of fiduciary duty and other violations of federal and state law with respect to proposed acquisition transactions. If you own shares of any of the below-referenced stocks and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, or calling toll free 877-534-2590. There is no cost or financial obligation to you.

Legg Mason, Inc. (NYSE:LM)

Under the terms of the agreement, Legg Mason shareholders will receive only $50.00 for each share of Legg Mason stock they own. The investigation concerns whether the Legg Mason Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether Franklin Resources is underpaying for the Company.

Additional information can be found at http://www.brodskysmith.com/cases/legg-mason-inc-nyse-lm/, or call 877-534-2590. No cost or obligation to you.

Neon Therapeutics, Inc. - (NASDAQGS:NTGN)

Under the terms of the agreement, Neon shareholders will receive only 0.063 shares of BioNTech in exchange for each share of Neon common stock owned, implying a per share amount of $2.18 as of the date of the announcement. The investigation concerns whether the Neon Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether the BioNTech is underpaying for the Company. For example, the consideration is well below the Company's 52-week high of $7.51.

Additional information can be found at http://www.brodskysmith.com/cases/neon-therapeutics-inc-nasdaqgs-ntgn, or call 877-534-2590. No cost or obligation to you.

Adesto Technologies Corporation (NASDAQGS:IOTS)

Under the terms of the agreement, Adesto shareholders will receive only $12.55 for each share of Adesto stock that they own. The investigation concerns whether the Adesto Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether Dialog is underpaying for the Company. For example, at least one financial analyst following the Company has set a price target of $13.00 for Adesto shares.

Additional information can be found at http://www.brodskysmith.com/cases/adesto-technologies-corporation-nasdaqgs-iots/, or call 877-534-2590. No cost or obligation to you.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

CONTACT: 

Marc Ackerman
610-667-6200
[email protected]

SOURCE: Brodsky & Smith, LLC

Topic:
Mergers and Acquisitions
Back to newsroom
Back to Newsroom
Share by: